AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic significance and comparative analysis in primary and metastatic tumors
Authors: Jimenez, RE Hussain, M Bianco, FJ Vaishampayan, U Tabazcka, P Sakr, WA Pontes, JE Wood, DP Grignon, DJ
Citation: Re. Jimenez et al., Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic significance and comparative analysis in primary and metastatic tumors, CLIN CANC R, 7(8), 2001, pp. 2440-2447
Neutron or photon irradiation for prostate tumors: Enhancement of cytokinetherapy in a metastatic tumor model
Authors: Hillman, GG Maughan, RL Grignon, DJ Yudelev, M Rubio, J Tekyi-Mensah, S Layer, A Che, MX Forman, JD
Citation: Gg. Hillman et al., Neutron or photon irradiation for prostate tumors: Enhancement of cytokinetherapy in a metastatic tumor model, CLIN CANC R, 7(1), 2001, pp. 136-144
Concurrent angiomyolipoma and renal cell neoplasia: A study of 36 cases
Authors: Jimenez, RE Eble, JN Reuter, VE Epstein, JI Folpe, AL de Peralta-Venturina, M Tamboli, P Ansell, ID Grignon, DJ Young, RH Amin, MB
Citation: Re. Jimenez et al., Concurrent angiomyolipoma and renal cell neoplasia: A study of 36 cases, MOD PATHOL, 14(3), 2001, pp. 157-163
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters
Authors: Merati, K Siadaty, MS Andea, A Sarkar, F Ben-Josef, E Mohammad, R Philip, P Shields, AF Vaitkevicius, V Grignon, DJ Adsay, NV
Citation: K. Merati et al., Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters, AM J CL ONC, 24(5), 2001, pp. 447-452
How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival?
Authors: Narain, V Bianco, FJ Grignon, DJ Sakr, WA Pontes, JE Wood, DP
Citation: V. Narain et al., How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival?, PROSTATE, 49(3), 2001, pp. 185-190
Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical prostatectomy
Authors: Shekarriz, B Upadhyay, J Bianco, FJ Tefilli, MV Tiguert, R Gheiler, EL Grignon, DJ Pontes, JE Wood, DP
Citation: B. Shekarriz et al., Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical prostatectomy, PROSTATE, 48(3), 2001, pp. 136-143
Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephroma
Authors: Pierson, CR Schober, MS Wallis, T Sarkar, FH Sorensen, PHB Eble, JN Srigley, JR Jones, EC Grignon, DJ Adsay, V
Citation: Cr. Pierson et al., Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephroma, HUMAN PATH, 32(5), 2001, pp. 513-520
Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma
Authors: Tiguert, R Bianco, FJ Oskanian, P Li, YW Grignon, DJ Wood, DP Pontes, JE Sarkar, FH
Citation: R. Tiguert et al., Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma, J UROL, 166(6), 2001, pp. 2155-2160
Pathology of kidney tumors
Authors: Grignon, DJ
Citation: Dj. Grignon, Pathology of kidney tumors, METH MOL M, 53, 2001, pp. 35-51
Epidemiology and molecular biology of early prostatic neoplasia
Authors: Sakr, WA Ward, C Grignon, DJ Haas, GP
Citation: Wa. Sakr et al., Epidemiology and molecular biology of early prostatic neoplasia, MOL UROL, 4(3), 2000, pp. 109-113
Significance of the Gleason scoring system after neoadjuvant hormonal therapy
Authors: Bentley, G Dey, J Sakr, WA Wood, DP Pontes, JE Grignon, DJ
Citation: G. Bentley et al., Significance of the Gleason scoring system after neoadjuvant hormonal therapy, MOL UROL, 4(3), 2000, pp. 125-129
Significance of the Gleason scoring system after neoadjuvant hormonal therapy - Open discussion following Dr. Grignon's presentation
Authors: Garnick, M Grignon, DJ Klotz, L Fair, W Bostwick, D Stone, N Porterfield, H Garzotto, M Moul, J Bruchovsky, N Heston, W
Citation: M. Garnick et al., Significance of the Gleason scoring system after neoadjuvant hormonal therapy - Open discussion following Dr. Grignon's presentation, MOL UROL, 4(3), 2000, pp. 131-131
Mixed epithelial and stromal tumor of the kidney
Authors: Adsay, NV Eble, JN Srigley, JR Jones, EC Grignon, DJ
Citation: Nv. Adsay et al., Mixed epithelial and stromal tumor of the kidney, AM J SURG P, 24(7), 2000, pp. 958-970
Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival
Authors: Jimenez, RE Gheiler, E Oskanian, P Tiguert, R Sakr, W Wood, DP Pontes, JE Grignon, DJ
Citation: Re. Jimenez et al., Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival, AM J SURG P, 24(7), 2000, pp. 980-987
Gleason score 7 prostate cancer: A heterogeneous entity? Correlation with pathologic parameters and disease-free survival
Authors: Sakr, WA Tefilli, MV Grignon, DJ Banerjee, M Dey, J Gheiler, EL Tiguert, R Powell, IJ Wood, DP
Citation: Wa. Sakr et al., Gleason score 7 prostate cancer: A heterogeneous entity? Correlation with pathologic parameters and disease-free survival, UROLOGY, 56(5), 2000, pp. 730-734
Impact of location and multifocality of positive surgical margins on disease-free survival following radical prostatectomy: A comparison between African-American and white men
Authors: Shekarriz, B Tiguert, R Upadhyay, J Gheiler, E Powell, IJ Pontes, JE Grignon, DJ Sakr, W Wood, DP
Citation: B. Shekarriz et al., Impact of location and multifocality of positive surgical margins on disease-free survival following radical prostatectomy: A comparison between African-American and white men, UROLOGY, 55(6), 2000, pp. 899-903
Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors
Authors: Tiguert, R Gheiler, EL Grignon, DJ Littrup, PJ Sakr, W Pontes, JE Wood, DP
Citation: R. Tiguert et al., Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors, J UROL, 163(5), 2000, pp. 1486-1490
College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what? Summary document and recommendations for implementation
Authors: Hammond, MEH Fitzgibbons, PL Compton, CC Grignon, DJ Page, DL Fielding, LP Bostwick, D Pajak, T
Citation: Meh. Hammond et al., College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what? Summary document and recommendations for implementation, ARCH PATH L, 124(7), 2000, pp. 958-965
Prognostic factors in prostate cancer - College of American Pathologists Consensus Statement 1999
Authors: Bostwick, DG Grignon, DJ Hammond, MEH Amin, MB Cohen, M Crawford, D Gospadarowicz, M Kaplan, RS Miller, DS Montironi, R Pajak, TF Pollack, A Srigley, JR Yarbro, JW
Citation: Dg. Bostwick et al., Prognostic factors in prostate cancer - College of American Pathologists Consensus Statement 1999, ARCH PATH L, 124(7), 2000, pp. 995-1000
Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland - A basis for checklists (Reprinted from Archives of Pathology & Laboratory Medicine, August, 1994)
Authors: Srigley, JR Amin, MB Bostwick, DG Grignon, DJ Hammond, MEH
Citation: Jr. Srigley et al., Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland - A basis for checklists (Reprinted from Archives of Pathology & Laboratory Medicine, August, 1994), ARCH PATH L, 124(7), 2000, pp. 1034-1039
Primary small cell carcinoma of the bladder.
Authors: Tiguert, R Ravery, V Gheiler, EL Grignon, DJ Gudziak, MR Wood, DP Pontes, JE
Citation: R. Tiguert et al., Primary small cell carcinoma of the bladder., PROG UROL, 9(2), 1999, pp. 256-260
Pathologic handling and reporting of prostate tissue specimens in patientsreceiving neoadjuvant hormonal therapy: Report of the Pathology Committee
Authors: Grignon, DJ Bostwick, DG Civantos, F Garnick, MB Gaudin, P Srigley, JR
Citation: Dj. Grignon et al., Pathologic handling and reporting of prostate tissue specimens in patientsreceiving neoadjuvant hormonal therapy: Report of the Pathology Committee, MOL UROL, 3(3), 1999, pp. 193-197
Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia
Authors: Upadhyay, J Shekarriz, B Nemeth, JA Dong, Z Cummings, GD Fridman, R Sakr, W Grignon, DJ Cher, ML
Citation: J. Upadhyay et al., Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia, CLIN CANC R, 5(12), 1999, pp. 4105-4110
Responsiveness of human prostate carcinoma bone tumors to interleukin-2 therapy in a mouse xenograft tumor model
Authors: Kocheril, SV Grignon, DJ Wang, CY Maughan, RL Montecillo, EJ Talati, B Tekyi-Mensah, S Pontes, JE Hillman, GG
Citation: Sv. Kocheril et al., Responsiveness of human prostate carcinoma bone tumors to interleukin-2 therapy in a mouse xenograft tumor model, CANCER DET, 23(5), 1999, pp. 408-416
p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: A molecular and immunohistochemical analysis
Authors: Rakozy, C Grignon, DJ Li, YW Gheiler, E Gururajanna, B Pontes, JE Sakr, W Wood, DP Sarkar, FH
Citation: C. Rakozy et al., p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: A molecular and immunohistochemical analysis, PATH RES PR, 195(3), 1999, pp. 129-135
Risultati: 1-25 | 26-36